檢索結果 - D. Phung

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials

    Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials 由 Fred Saad, Cristina Ivanescu, D. Phung, Yohann Loriot, Sarang Abhyankar, Tomasz M. Beer, Bertrand Tombal, Stefan Holmström

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

    Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer 由 Andrew J. Armstrong, Po‐Han Lin, Celestia S. Higano, Cora N. Sternberg, Guru Sonpavde, Bertrand Tombal, Arnoud J. Templeton, Karim Fizazi, D. Phung, Esther Kam Yin Wong, Andrew Krivoshik, Tomasz M. Beer

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region

    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of... 由 Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, Ugo De Giorgi, Eleni Efstathiou, Ubirajara Ferreira, Petro Ivashchenko, Katarzyna Madziarska, Mohammed Al-Adhami, Katharina Modelska, D. Phung, Joyce Steinberg, Cora N. Sternberg

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL

    Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL 由 Alan H. Bryce, Joshi J. Alumkal, Andrew J. Armstrong, Celestia S. Higano, Peter Iversen, Cora N. Sternberg, Dana E. Rathkopf, Yohann Loriot, Johann S. de Bono, Bertrand Tombal, Sarang Abhyankar, Po‐Han Lin, Andrew Krivoshik, D. Phung, Tomasz M. Beer

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

    Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial 由 Thomas J. Schnitzer, María Pueyo, H. Deckx, Ellen van der Aar, Katy Bernard, S Hatch, M. van der Stoep, S. Grankov, D. Phung, O. Imbert, D. Chimits, K. Müller, Marc C. Hochberg, Henning Bliddal, W. Wirth, F. Eckstein, Philip G. Conaghan

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: